在传统IA诱导方案基础上加用洛莫司汀可改善老年原发性AML患者的预后
The Journal of Evidence-Based Medicine（2013）
摘要
<正>1文献来源Pigneux A,Harousseau JL,Witz F,et al.Addition of Lomustine to Idarubicin and Cytarabine improves the outcome of elderly patients with De Novo acute myeloid leukemia:A report from the GOELAMS[J].J Clin Oncol,2010,28(18):3028-3034.2证据水平2a。3背景急性髓性白血病(acute myeloid leukemia,
更多关键词
Lomustine,induction,acute myeloid leukemia,elderly
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要